Aspen Aerogels, Inc.
Symbol: ASPN (NYSE)
Company Description:
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.
- Today's Open: $6.21
- Today's High: $6.575
- Today's Low: $6.195
- Today's Volume: 559.27K
- Yesterday Close: $6.27
- Yesterday High: $6.69
- Yesterday Low: $6.225
- Yesterday Volume: 2.24M
- Last Min Volume: 6.69K
- Last Min High: $6.501
- Last Min Low: $6.495
- Last Min VWAP: $6.495
- Name: Aspen Aerogels, Inc.
- Website: https://www.aerogel.com
- Listed Date: 2014-06-13
- Location: NORTHBOROUGH, MA
- Market Status: Active
- CIK Number: 0001145986
- SIC Code: 5030
- SIC description: WHOLESALE-LUMBER & OTHER CONSTRUCTION MATERIALS
- Market Cap: $516.40M
- Round Lot: 100
- Outstanding Shares: 82.36M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-09-08 | 4 | View |
2025-08-13 | 4 | View |
2025-08-12 | 144 | View |
2025-08-07 | 10-Q | View |
2025-08-07 | 8-K | View |
2025-05-27 | 4 | View |
2025-05-15 | SCHEDULE 13G/A | View |
2025-05-15 | SCHEDULE 13G/A | View |
2025-05-12 | 4 | View |
2025-05-08 | S-8 | View |
2025-05-08 | S-8 | View |
2025-05-08 | 10-Q | View |
2025-05-08 | 8-K | View |
2025-05-01 | 4 | View |
2025-05-01 | 4 | View |
2025-05-01 | 4 | View |
2025-05-01 | 4 | View |
2025-05-01 | 4 | View |
2025-05-01 | 8-K | View |
2025-03-17 | ARS | View |